STRONG II trial : stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma – a single-arm multicentre phase II study

Source
BMJ open - ISSN 2044-6055-15:7 (2025) p. 1-11
Author(s)
    Suus Y. van Loosbroek, Maaike T.W. Milder, Dirk de Ruysscher, Rianne D.W. Vaes, Wilhelm den Toom, François Willemssen, Ferry Eskens, Marjolein Y.V. Homs, Bas Groot Koerkamp, Lydi M.J.W van Driel, Yvette Seppenwoolde, Erik van Werkhoven, Martijn Intven, Nadia Haj Mohammad, Joep de Bruijne, Eva Versteijne, Anna M. Bruynzeel, Freek Brandts, Joris I. Erdmann, Harm Westdorp, Pètra M. Braam, Eric T.T.L. Tjwa, Christelle Bouchart, Anne Demols, Akos Gulyban, Jeroen Buijsen, Judith de Vos-Geelen, Maxime Dewulf, Ines Joye, Timon Vandamme, Luisa Vonghia, Derk Jan de Groot, Margriet Dieters, Fred J.F. Ubbels, Frederik J.H. Hoogwater, Ben Heijmen, Alejandra Méndez Romero

Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients : a randomised pragmatic trial (SHAPERS)

Source
ESMO gastrointestinal oncology - ISSN 2949-8198-4 (2024) p. 1-6
Author(s)
    R. Saúde-Conde, Timon Vandamme, M. De Backer, P. Martinive, A. Covas, A. Deleporte, A. Dermine, F. Forget, K. Geboes, Q. Gilliaux, Y. Gokburun, E. Gonne, Ines Joye, S. Lecomte, G. Liberale, W. Lybaert, L. Moretti, L. Mortier, S. Mupingu Mwanawa, F. Puleo, E.D. Saad, I. Sinapi, L. Annemans, M. Buyse, F. Sclafani

Long-term results of a phase 1 dose escalation trial of ablative stereotactic body radiation therapy

Source
International journal of radiation oncology, biology, physics - ISSN 0360-3016-118:5 (2024) p. 1490-1496
Author(s)

Completeness of reporting oligometastatic disease characteristics in the literature and influence on oligometastatic disease classification using the ESTRO/EORTC nomenclature

Source
International journal of radiation oncology, biology, physics - ISSN 0360-3016-114:4 (2022) p. 587-595
Author(s)